Inflammation-associated cancer development in digestive organs: Mechanisms and roles for genetic and epigenetic modulation

Gastroenterology

Volumn 143, Issue 3, 2012, Pages 550-563

  Chiba, Tsutomu ^a   Marusawa, Hiroyuki ^a   Ushijima, Toshikazu ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Epigenetics; H pylori; HCV; Mutation Induction

Indexed keywords

ABELSON KINASE; BREAKPOINT CLUSTER REGION PROTEIN; CURCUMIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLOOXYGENASE 2; CYTIDINE DEAMINASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; HISTONE H2A; HISTONE H2B; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; K RAS PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 155; MICRORNA 7; NITRIC OXIDE SYNTHASE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RESVERATROL; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR EZH2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; BARRETT ESOPHAGUS; BILE DUCT CARCINOMA; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; COLITIS; COLITIS ASSOCIATED COLON CANCER; COLON CANCER; COLORECTAL CANCER; COPY NUMBER VARIATION; CPG ISLAND; CYTOKINE RESPONSE; DIGESTIVE SYSTEM CANCER; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION; DNA REPLICATION; DNA STRAND BREAKAGE; DRUG SAFETY; ENZYME ACTIVATION; EPIGENETICS; GENE DELETION; GENE DUPLICATION; GENE LOCUS; GENE REARRANGEMENT; GENETIC RECOMBINATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HISTONE MODIFICATION; HUMAN; IMMUNOGLOBULIN GENE; LIVER CELL CARCINOMA; LYMPHOMA; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; POINT MUTATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; SOMATIC HYPERMUTATION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; WEIGHT REDUCTION;

EID: 84865510127     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.07.009     Document Type: Review

References (170)

1. L.M. Coussens, Z. Werb Inflammation and cancer Nature 420 2002 860 867 (Pubitemid 36019639)
2. H. Walczak TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer Immunol Rev 244 2011 9 28
3. J.M. Yeh, S.J. Goldie, K.M. Kuntz Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections Cancer Causes Control 20 2009 2021 2029
4. B.J. Vennervald, K. Polman Helminths and malignancy Parasite Immunol 31 2009 686 696
5. F. Balkwill, A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545 (Pubitemid 32173595)
6. S.P. Hussain, C.C. Harris Inflammation and cancer: an ancient link with novel potentials Int J Cancer 121 2007 2373 2380 (Pubitemid 350022405)
7. A. Mantovani, P. Allavena, A. Sica Cancer-related inflammation Nature 454 2008 436 444
8. P.J. Stephens, D.J. McBride, M.L. Lin Complex landscapes of somatic rearrangement in human breast cancer genomes Nature 462 2009 1005 1010
9. E.D. Pleasance, P.J. Stephens, S. O'Meara A small-cell lung cancer genome with complex signatures of tobacco exposure Nature 463 2010 184 190
10. T. Sjoblom, S. Jones, L.D. Wood The consensus coding sequences of human breast and colorectal cancers Science 314 2006 268 274 (Pubitemid 44571966)
11. E.D. Pleasance, R.K. Cheetham, P.J. Stephens A comprehensive catalogue of somatic mutations from a human cancer genome Nature 463 2010 191 196
12. C. Kumar-Sinha, S.A. Tomlins, A.M. Chinnaiyan Recurrent gene fusions in prostate cancer Nat Rev Cancer 8 2008 497 511
13. T. Ushijima, N. Hattori molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers Clin Cancer Res 18 2012 923 929
14. T. Ushijima, K. Asada Aberrant DNA methylation in contrast with mutations Cancer Sci 101 2010 300 305
15. T. Maekita, K. Nakazawa, M. Mihara High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk Clin Cancer Res 12 2006 989 995 (Pubitemid 43259882)
16. T. Niwa, T. Tsukamoto, T. Toyoda Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells Cancer Res 70 2010 1430 1440
17. A. Jemal, F. Bray, M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
18. S.F. Altekruse, K.A. McGlynn, M.E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 2009 1485 1491
19. J.R. Warren, B. Marshall Unidentified curved bacilli on gastric epithelium in active chronic gastritis Lancet 1 1983 1273 1275
20. N. Uemura, S. Okamoto, S. Yamamoto Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 2001 784 789
21. T. Chiba, H. Marusawa, H. Seno Mechanism for gastric cancer development by Helicobacter pylori infection J Gastroenterol Hepatol 23 2008 1175 1181
22. D.M. Parkin The global health burden of infection-associated cancers in the year 2002 Int J Cancer 118 2006 3030 3044
23. C.N. Bernstein, J.F. Blanchard, E. Kliewer Cancer risk in patients with inflammatory bowel disease: a population-based study Cancer 91 2001 854 862 (Pubitemid 32173312)
24. J. Askling, M. Linet, G. Gridley Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis Gastroenterology 123 2002 1428 1435 (Pubitemid 35231641)
25. P. Elfstrom, F. Granath, W. Ye Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease Clin Gastroenterol Hepatol 10 2012 30 36
26. T. Patel Cholangiocarcinoma Nat Clin Pract Gastroenterol Hepatol 3 2006 33 42 (Pubitemid 43102075)
27. M.H. Imam, M.G. Silveira, E. Sinakos Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinoma Clin Gastroenterol Hepatol 10 2012 182 185
28. N.J. Shaheen, J.E. Richter Barrett's oesophagus Lancet 373 2009 850 861
29. E.P. DiMagno, H.A. Reber, M.A. Tempero AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma American Gastroenterological Association Gastroenterology 117 1999 1464 1484
30. D.C. Whitcomb, S. Applebaum, S.P. Martin Hereditary pancreatitis and pancreatic carcinoma Ann N Y Acad Sci 880 1999 201 209 (Pubitemid 29349128)
31. A.C. Wotherspoon, C. Doglioni, T.C. Diss Regression of promary low-grade B cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori Lancet 342 1993 575 577 (Pubitemid 23259233)
32. Y. Kodama, K. Kawabata, S. Yoshida Malt lymphoma simulating an extramedullary plasmacytoma of the stomach Am J Med 107 1999 530 532 (Pubitemid 29528350)
33. S.K. Hartridge-Lambert, E.M. Stein, A.J. Markowitz Hepatitis C and non-hodgkin lymphoma: the clinical perspective Hepatology 55 2012 634 641
34. K.E. Smedby, M. Akerman, H. Hildebrand Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma Gut 54 2005 54 59 (Pubitemid 40007218)
35. E.M. El-Omar, M. Carrington, W.H. Chow Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 2000 398 402 (Pubitemid 30164342)
36. Y. Ben-Neriah, M. Karin Inflammation meets cancer, with NF-kappaB as the matchmaker Nat Immunol 12 2011 715 723
37. A. Kuraishy, M. Karin, S.I. Grivennikov Tumor promotion via injury- and death-induced inflammation Immunity 35 2011 467 477
38. S.P. Hussain, L.J. Hofseth, C.C. Harris Radical causes of cancer Nat Rev Cancer 3 2003 276 285 (Pubitemid 37328863)
39. D. Wang, R.N. DuBois Eicosanoids and cancer Nat Rev Cancer 10 2010 181 193
40. D. Ziech, R. Franco, A. Pappa Reactive oxygen species (ROS)induced genetic and epigenetic alterations in human carcinogenesis Mutat Res 711 2011 167 173
41. A. Sekikawa, H. Fukui, S. Fujii REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells Carcinogenesis 29 2008 76 83 (Pubitemid 351201744)
42. K. Kanda, H. Komekado, T. Sawabu Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-alpha EMBO Mol Med 4 2012 396 411
43. A.R. Schievella, J.H. Chen, J.R. Graham MADD, a novel death domain protein that interacts with the type I tumor necrosis factor receptor and activates mitogen-activated protein kinase J Biol Chem 272 1997 12069 12075 (Pubitemid 27202786)
44. D. Kamimura, K. Ishihara, T. Hirano IL6-signal transduction and its physiological roles: the signal orchestration model Rev Physiol Biochem Pharmacol 149 2003 1 38
45. F. Chen JNK-induced apoptosis, compensatory growth, and cancer stem cells Cancer Res 72 2012 379 386
46. J. Liu, J. Yan, S. Jiang Site-specific ubiquitination is required for releaving the transcription factor Miz1-mediated suppresion on TNFα-induced JNK activation and inflammation Proc Natl Acad Sci U S A 109 2012 191 196
47. S. Inokuchi, T. Aoyama, K. Miura Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis and carcinogenesis Proc Natl Acad Sci U S A 107 2010 844 849
48. Q. Chang, Y. Zhang, K.J. Beezhold Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer J Hepatol 50 2009 323 333
49. H. Higashi, R. Tsutsumi, S. Muto SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein Science 295 2002 683 686 (Pubitemid 34111828)
50. J.L. Snider, C. Allison, B.H. Bellaire The beta1 integrin activates JNK independent of CagA, and JNK actvation is required for Helicobacter pylori CagA+-induced motility of gastric cancer cells J Biol Chem 283 2008 13952 13963
51. D. Hanahan, R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70 (Pubitemid 30046295)
52. A.C. Joerger, A.R. Fersht Structure-function-rescue: the diverse nature of common p53 cancer mutants Oncogene 26 2007 2226 2242 (Pubitemid 46536643)
53. T.A. Brentnall, R.C. Haggitt, P.S. Rabinovitch Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis Gastroenterology 110 1996 331 338 (Pubitemid 26043863)
54. S.P. Hussain, P. Amstad, K. Raja Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease Cancer Res 60 2000 3333 3337 (Pubitemid 30482141)
55. M.T. Barrett, C.A. Sanchez, L.J. Prevo Evolution of neoplastic cell lineages in Barrett oesophagus Nat Genet 22 1999 106 109 (Pubitemid 29214816)
56. T. Kou, H. Marusawa, K. Kinoshita Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis Int J Cancer 120 2007 469 476 (Pubitemid 44969015)
57. S.J. Leedham, T.A. Graham, D. Oukrif Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia Gastroenterology 136 2009 542 550
58. K. Machida, K.T. Cheng, V.M. Sung Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes J Virol 78 2004 8835 8843 (Pubitemid 39025148)
59. S.P. Hussain, P. He, J. Subleski Nitric oxide is a key component in inflammation-accelerated tumorigenesis Cancer Res 68 2008 7130 7136
60. B. Demple, L. Harrison Repair of oxidative damage to DNA: enzymology and biology Annu Rev Biochem 63 1994 915 948 (Pubitemid 24218652)
61. A. Federico, F. Morgillo, C. Tuccillo Chronic inflammation and oxidative stress in human carcinogenesis Int J Cancer 121 2007 2381 2386 (Pubitemid 350022406)
62. C. Gasche, C.L. Chang, J. Rhees Oxidative stress increases frameshift mutations in human colorectal cancer cells Cancer Res 61 2001 7444 7448 (Pubitemid 32995032)
63. T.D. Halazonetis, V.G. Gorgoulis, J. Bartek An oncogene-induced DNA damage model for cancer development Science 319 2008 1352 1355 (Pubitemid 351354863)
64. O. Vafa, M. Wade, S. Kern c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability Mol Cell 9 2002 1031 1044 (Pubitemid 34626672)
65. M.D. Evans, M. Dizdaroglu, M.S. Cooke Oxidative DNA damage and disease: induction, repair and significance Mutat Res 567 2004 1 61 (Pubitemid 39162992)
66. T. Takahashi, M.M. Nau, I. Chiba p53: a frequent target for genetic abnormalities in lung cancer Science 246 1989 491 494 (Pubitemid 19273938)
67. I.C. Hsu, R.A. Metcalf, T. Sun Mutational hotspot in the p53 gene in human hepatocellular carcinomas Nature 350 1991 427 428 (Pubitemid 21912245)
68. C. Greenman, P. Stephens, R. Smith Patterns of somatic mutation in human cancer genomes Nature 446 2007 153 158 (Pubitemid 46398669)
69. S.G. Conticello The AID/APOBEC family of nucleic acid mutators Genome Biol 9 2008 229
70. M. Liu, J.L. Duke, D.J. Richter Two levels of protection for the B cell genome during somatic hypermutation Nature 451 2008 841 845 (Pubitemid 351253166)
71. T. Honjo, K. Kinoshita, M. Muramatsu Molecular mechanism of class switch recombination: linkage with somatic hypermutation Annu Rev Immunol 20 2002 165 196 (Pubitemid 34293423)
72. J. Greeve, A. Philipsen, K. Krause Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas Blood 101 2003 3574 3580 (Pubitemid 36857944)
73. L. Pasqualucci, R. Guglielmino, J. Houldsworth Expression of the AID protein in normal and neoplastic B cells Blood 104 2004 3318 3325 (Pubitemid 39507152)
74. D.F. Robbiani, A. Bothmer, E. Callen AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations Cell 135 2008 1028 1038
75. L. Klemm, C. Duy, I. Iacobucci The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia Cancer Cell 16 2009 232 245
76. H. Nagaoka, T.H. Tran, M. Kobayashi Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity Int Immunol 22 2010 227 235
77. Y. Endo, H. Marusawa, K. Kinoshita Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling Oncogene 26 2007 5587 5595 (Pubitemid 47267836)
78. H. Marusawa, M. Hijikata, T. Chiba Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation J Virol 73 1999 4713 4720 (Pubitemid 29246730)
79. Y. Matsumoto, H. Marusawa, K. Kinoshita Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium Nat Med 13 2007 470 476 (Pubitemid 46559833)
80. Y. Endo, H. Marusawa, T. Kou Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers Gastroenterology 135 2008 889 898
81. J. Komori, H. Marusawa, T. Machimoto Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma Hepatology 47 2008 888 896 (Pubitemid 351449680)
82. S. Morita, Y. Matsumoto, S. Okuyama Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma Carcinogenesis 32 2011 1706 1712
83. I.M. Okazaki, H. Hiai, N. Kakazu Constitutive expression of AID leads to tumorigenesis J Exp Med 197 2003 1173 1181 (Pubitemid 36570072)
84. T. Morisawa, H. Marusawa, Y. Ueda Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression Int J Cancer 123 2008 2735 2740
85. C. Almoguera, D. Shibata, K. Forrester Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 1988 549 554
86. S.S. Thorgeirsson, J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 2002 339 346 (Pubitemid 35154440)
87. Y. Matsumoto, H. Marusawa, K. Kinoshita Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer Gastroenterology 139 2010 1984 1994
88. N. Feldhahn, N. Henke, K. Melchior Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells J Exp Med 204 2007 1157 1166 (Pubitemid 46798158)
89. A. Takai, H. Marusawa, Y. Minaki Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation Oncogene 31 2012 1733 1742
90. P.A. Jones, S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692 (Pubitemid 46273572)
91. T.A. Rauch, X. Wu, X. Zhong A human B cell methylome at 100-base pair resolution Proc Natl Acad Sci U S A 106 2009 671 678
92. R. Lister, M. Pelizzola, R.H. Dowen Human DNA methylomes at base resolution show widespread epigenomic differences Nature 462 2009 315 322
93. B. Li, M. Carey, J.L. Workman The role of chromatin during transcription Cell 128 2007 707 719 (Pubitemid 46273570)
94. J.C. Lin, S. Jeong, G. Liang Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island Cancer Cell 12 2007 432 444 (Pubitemid 350046405)
95. S. Yamashita, K. Hosoya, K. Gyobu Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis DNA Res 16 2009 275 286
96. Y. Kondo, L. Shen, A.S. Cheng Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation Nat Genet 40 2008 741 750 (Pubitemid 351748874)
97. R. Margueron, D. Reinberg Chromatin structure and the inheritance of epigenetic information Nat Rev Genet 11 2010 285 296
98. A.P. Feinberg, B. Tycko The history of cancer epigenetics Nat Rev Cancer 4 2004 143 153 (Pubitemid 38198742)
99. T. Yoshida, S. Yamashita, T. Takamura-Enya Alu and Satα hypomethylation in Helicobacter pylori-infected gastric mucosae Int J Cancer 128 2011 33 39
100. T.A. Rauch, X. Zhong, X. Wu High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer Proc Natl Acad Sci U S A 105 2008 252 257
101. H. Takeshima, T. Ushijima Methylation destiny: Moira takes account of histones and RNA polymerase II Epigenetics 5 2010 89 95
102. H. Takeshima, S. Yamashita, T. Shimazu The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands Genome Res 19 2009 1974 1982
103. R.Z. Chen, U. Pettersson, C. Beard DNA hypomethylation leads to elevated mutation rates Nature 395 1998 89 93 (Pubitemid 28420236)
104. S. Enroth, A. Rada-Iglesisas, R. Andersson Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa BMC Cancer 11 2011 450
105. J.P. Issa, Y.L. Ottaviano, P. Celano Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Nat Genet 7 1994 536 540 (Pubitemid 24308343)
106. C.J. Hsieh, B. Klump, K. Holzmann Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis Cancer Res 58 1998 3942 3945 (Pubitemid 28405652)
107. J.P. Issa, N. Ahuja, M. Toyota Accelerated age-related CpG island methylation in ulcerative colitis Cancer Res 61 2001 3573 3577 (Pubitemid 32694963)
108. Y. Kondo, Y. Kanai, M. Sakamoto Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosisa comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma Hepatology 32 2000 970 979
109. T. Nakajima, T. Maekita, I. Oda Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers Cancer Epidemiol Biomarkers Prev 15 2006 2317 2321 (Pubitemid 44877064)
110. L. Shen, Y. Kondo, G.L. Rosner MGMT promoter methylation and field defect in sporadic colorectal cancer J Natl Cancer Inst 97 2005 1330 1338 (Pubitemid 41487800)
111. P.S. Yan, C. Venkataramu, A. Ibrahim Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue Clin Cancer Res 12 2006 6626 6636 (Pubitemid 44876830)
112. E. Arai, Y. Kanai, S. Ushijima Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues Int J Cancer 119 2006 288 296
113. T. Ushijima Epigenetic field for cancerization J Biochem Mol Biol 40 2007 142 150 (Pubitemid 46515191)
114. C.M. Shin, N. Kim, J.H. Park Prediction of the risk for gastric ancer using candidate methylation markers in the non-neoplastic gastric mucosae J Pathol 226 2012 654 665
115. K. Hur, T. Niwa, T. Toyoda Insufficient role of cell proliferation in aberrant DNA methylation induction and involvement of specific types of inflammation Carcinogenesis 32 2011 35 41
116. E.J. Yoo, S.Y. Park, N.Y. Cho Influence of IL1B polymorphism on CpG island hypermethylation in Helicobacter pylori-infected gastric cancer Virchows Arch 456 2010 647 652
117. D.W. Rosenberg, C. Giardina, T. Tanaka Mouse models for the study of colon carcinogenesis Carcinogenesis 30 2009 183 196
118. M. Katsurano, T. Niwa, Y. Yasui Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction Oncogene 31 2012 342 351
119. A. Hmadcha, F.J. Bedoya, F. Sobrino Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production J Exp Med 190 1999 1595 1604
120. D.R. Hodge, W. Xiao, P.A. Clausen Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells J Mol Biol 276 2001 39508 39511
121. C. Braconi, N. Huang, T. Patel MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes Hepatology 51 2010 881 890
122. D. Xia, D. Wang, S.H. Kim Prostaglandin E(2) promotes intestinal tumor growth via DNA methylation Nat Med 18 2012 224 226
123. T. Nakajima, S. Yamashita, T. Maekita The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae Int J Cancer 124 2009 905 910
124. H.M. O'Hagan, W. Wang, S. Sen Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands Cancer Cell 20 2011 606 619
125. C. Stirzaker, J.Z. Song, B. Davidson Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells Cancer Res 64 2004 3871 3877 (Pubitemid 38697298)
126. T. Ushijima, N. Watanabe, K. Shimizu Decreased fidelity in replicating CpG methylation patterns in cancer cells Cancer Res 65 2005 11 17 (Pubitemid 40070790)
127. M. Ehrlich DNA hypomethylation in cancer cells Epigenomics 1 2009 239 259
128. J.M. Bae, S.H. Shin, H.J. Kwon ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications Int J Cancer 131 2012 1323 1331
129. S. Cortellino, J. Xu, M. Sannai Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair Cell 146 2011 67 79
130. J.U. Guo, Y. Su, C. Zhong Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain Cell 145 2011 423 434
131. E.L. Fritz, N. Papavasiliou Cytidine deaminases: AIDing DNA demethylation? Genes Dev 24 2010 2107 2114
132. L. Kato, N.A. Begum, A.M. Burroughs Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes Proc Natl Acad Sci U S A 109 2012 2479 2484
133. G. Di Leva, C.M. Croce Roles of small RNAs in tumor formation Trends Mol Med 16 2010 257 267
134. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 10 2009 704 714
135. J. Lu, G. Getz, E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838 (Pubitemid 40839735)
136. E. Sonkoly, A. Pivarcsi MicroRNAs in inflammation and response to injuries induced by environmental pollution Mutat Res 717 2011 46 53
137. R.M. O'Connell, D.S. Rao, D. Baltimore MicroRNA regulation of inflammatory responses Annu Rev Immunol 30 2012 295 312
138. J.L. Zhao, D.S. Rao, M.P. Boldin NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies Proc Natl Acad Sci U S A 108 2011 9184 9189
139. K.A. Padgett, R.Y. Lan, P.C. Leung Primary biliary cirrhosis is associated with altered hepatic microRNA expression J Autoimmun 32 2009 246 253
140. F. Wu, M. Zikusoka, A. Trindade MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha Gastroenterology 135 2008 1624 1635
141. A.J. Schetter, N.H. Heegaard, C.C. Harris Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways Carcinogenesis 31 2010 37 49
142. D. Kong, Y.S. Piao, S. Yamashita Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells Oncogene 2011 10.1038/onc.2011.558
143. E. Tili, J.J. Michaille, D. Wernicke Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer Proc Natl Acad Sci U S A 108 2011 4908 4913
144. S.M. Johnson, H. Grosshans, J. Shingara RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647 (Pubitemid 40343076)
145. Y. Akao, Y. Nakagawa, T. Naoe let-7 microRNA functions as a potential growth suppressor in human colon cancer cells Biol Pharm Bull 29 2006 903 906
146. G.A. Calin, C. Sevignani, C.D. Dumitru Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc Natl Acad Sci U S A 101 2004 2999 3004 (Pubitemid 38327724)
147. D. Iliopoulos, H.A. Hirsch, K. Struhl An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation Cell 139 2009 693 706
148. E. Tili, C.M. Croce, J.J. Michaille MiR-155: on the crosstalk between inflammation and cancer Int Rev Immunol 28 2009 264 284
149. S. Volinia, G.A. Calin, C.G. Liu A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 2006 2257 2261 (Pubitemid 43271657)
150. R.M. O'Connell, K.D. Taganov, M.P. Boldin MicroRNA-155 is induced during the macrophage inflammatory response Proc Natl Acad Sci U S A 104 2007 1604 1609 (Pubitemid 46214637)
151. B. Xiao, Z. Liu, B.S. Li Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response J Infect Dis 200 2009 916 925
152. N. Valeri, P. Gasparini, M. Fabbri Modulation of mismatch repair and genomic stability by miR-155 Proc Natl Acad Sci U S A 107 2010 6982 6987
153. G. Teng, P. Hakimpour, P. Landgraf MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase Immunity 28 2008 621 629
154. Y. Dorsett, K.M. McBride, M. Jankovic MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation Immunity 28 2008 630 638
155. J.R. Pekow, J.H. Kwon MicroRNAs in inflammatory bowel disease Inflamm Bowel Dis 18 2012 187 193
156. D. Iliopoulos, S.A. Jaeger, H.A. Hirsch STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer Mol Cell 39 2010 493 506
157. A.V. Olaru, F.M. Selaru, Y. Mori Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation Inflamm Bowel Dis 17 2011 221 231
158. P.M. Rothwell, F.G. Fowkes, J.F. Belch Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Lancet 377 2011 31 41
159. B.B. Aggarwal, B. Sung Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets Trends Pharmacol Sci 30 2009 85 94
160. M. Kanai, A. Imaizumi, Y. Otsuka Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Cancer Chemother Pharmacol 69 2012 65 70
161. Z.Y. He, C.B. Shi, H. Wen Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin Cancer Invest 29 2011 208 213
162. D. Delmas, A. Lancon, D. Colin Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer Current Drug Targets 7 2006 423 442 (Pubitemid 43744833)
163. E. Tili, J.J. Michaille, B. Adair Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD Carcinogenesis 31 2010 1561 1566
164. B.B. Aggarwal, M.E. Van Kuiken, L.H. Iyer Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis Exp Biol Med 234 2009 825 849
165. K. Fukase, M. Kato, S. Kikuchi Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 2008 392 397
166. K. Ikeda, H. Marusawa, Y. Osaki Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study Ann Intern Med 146 2007 649 656 (Pubitemid 351650520)
167. Y. Sato, S. Takahashi, Y. Kinouchi IL-10 deficiency leads to somatic mutations in a model of IBD Carcinogenesis 27 2006 1068 1073
168. T. Ando, T. Yoshida, S. Enomoto DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect Int J Cancer 124 2009 2367 2374
169. S. Nanjo, K. Asada, S. Yamashita Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection Gastric Cancer 2012 [Epub ahead of print]
170. M. Toyota, N. Ahuja, M. Ohe-Toyota CpG island methylator phenotype in colorectal cancer Proc Natl Acad Sci U S A 96 1999 8681 8686 (Pubitemid 29354851)